France-based Novacyt S.A. (OTC:NVYTF -29.9%) announces that
unit Primerdesign has achieved a production run-rate of 4M per month of
its COVID-19 molecular test with plans to scale up to 8M per month.
Anticipating strong ongoing demand, it has inked
manufacturing deals with two UK-based firms aimed at supporting its
existing partnership agreements.
https://seekingalpha.com/news/3560941-novacyt-ramping-up-production-of-covidminus-19-test-amid-significant-demand
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.